Overview
- Doximity stock surged about 105% in premarket trading on Friday after the company’s earnings call and management comments focused on clinical artificial intelligence.
- The quarter delivered mixed results with revenue of $156.6 million that beat estimates while adjusted EPS of $0.29 narrowly missed consensus and adjusted EBITDA topped forecasts.
- Management raised the full‑year revenue midpoint to $676 million even as it set a lower adjusted EBITDA midpoint and reported a quarterly operating margin of 21.5%, down from 37.4% a year earlier.
- Independent academic testing by Stanford and Harvard found Doximity’s Ask AI outperformed U.S. rivals and the company reported a tenfold year‑over‑year jump in Scribe users in July, signals the CEO used to argue strong unit economics for AI search.
- The market move shows investors are pricing AI momentum into Doximity’s value but analysts warn slower revenue growth expectations and margin compression mean the rally will hinge on whether AI features translate into sustained revenue and profit gains.